Forecast Next Dividend Date: Wednesday 20 March 2019
Days remaining until next forecast dividend: 29
This is only a forecast. Forecast ex-dividend dates are taken from company's website or by using previous ex-dividend dates as a guide. Please confirm ex-dividend date with your broker.
Dividend Star Rating for PROBIOTEC(PBP)
Fundamental Data for PROBIOTEC(PBP)Sector: Pharmaceuticals Biotechnology & Li Price: $1.51 (delayed) Year High: $1.80 Year Low: $0.47 Market Capitalisation: $0.104 billion Net Tangible Assets: $0 billion Earnings per Share: 0 cents Price Earnings Ratio: 29 Forecast Earnings Growth (5 years): 0% per annum Dividend Cover: 2.08
Dividend Payment History for PROBIOTEC(PBP)
|Ex-Dividend Date||Books Close Date||Date Payable||Amount||Franking||Franking Credit||Gross Dividend||Cum Div Price||Gross Yield||RoI|
- Care should be taken interpreting this chart as all dividend payments for final year may not have been paid.
- The financial year that the dividend is allocated depends on the payment date of the dividend, not the ex-dividend date.
- Dividend history has not been adjusted for any capital reconstructions which may have effected dividend entitlement per share.
Dividend News Articles for PROBIOTEC(PBP)
|Probiotec sells brand assets to iNova Pharmaceuticals - Small Caps|
Probiotec sells brand assets to iNova Pharmaceuticals Small Caps
Pharmaceutical company Probiotec (ASX: PBP) has agreed to sell the Gold Cross, David Craig and Skin Basics brands, including all intellectual property and ...
|Blackmores Share Price Rises on New Acquisition and Record Sales - Money Morning Australia|
Blackmores Share Price Rises on New Acquisition and Record Sales Money Morning Australia
Blackmores Limited [ASX:BKL] share price increased immediately upon opening, after revealing the acquisition of Probiotec Limited's [ASX:PBP] IMPROMY ...
|Why wellness stock Probiotec is a picture of health - Stockhead|
Why wellness stock Probiotec is a picture of health Stockhead
Looking for a healthier, more diverse ASX portfolio? Our resident expert Tim Boreham explains why you need to be investing in probiotic health stocks.
|VICOM Ltd (SGX:V01): Did It Outperform The Industry? - Simply Wall St|
VICOM Ltd (SGX:V01): Did It Outperform The Industry? Simply Wall St
After reading VICOM Ltd's (SGX:V01) latest earnings update (30 June 2018), I found it beneficial to look back at how the company has performed in the past and ...
|Should Investors Hold Tight To Probiotec Limited (ASX:PBP) In Their Porfolio With Sales Growth of 0.19455? - Troy Business News|
Should Investors Hold Tight To Probiotec Limited (ASX:PBP) In Their Porfolio With Sales Growth of 0.19455? Troy Business News
Potential Investors often look for key drivers that can move a stock in a positive direction. One of those is sales growth. Probiotec Limited (ASX:PBP) of the ...